Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]

7728 reported adverse events

Drugs of this class: PERAMPANEL

These side effects are most commonly reported by patients taking drugs of the Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] class:

# Side effect Count
0 SEIZURE 1171
1 DRUG INEFFECTIVE 1129
2 OFF LABEL USE 830
3 SOMNOLENCE 525
4 AGGRESSION 504
5 DIZZINESS 408
6 EPILEPSY 377
7 STATUS EPILEPTICUS 350
8 DRUG INTERACTION 343
9 MULTIPLE-DRUG RESISTANCE 332
See all common reactions for Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]

Drugs of the Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEW ONSET REFRACTORY STATUS EPILEPTICUS 36 0.3273
1 POSTICTAL PARALYSIS 27 0.1116
2 MULTIPLE-DRUG RESISTANCE 332 0.1070
3 SEIZURE CLUSTER 50 0.0603
4 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 32 0.0598
5 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 29 0.0446
6 ATONIC SEIZURES 38 0.0442
7 ANTICONVULSANT DRUG LEVEL INCREASED 55 0.0340
8 STATUS EPILEPTICUS 350 0.0310
9 FOCAL DYSCOGNITIVE SEIZURES 35 0.0307
See all enriched reactions for Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]